Mr Daniel Wilby, Consultant Urological Surgeon

Mr Daniel Wilby

Consultant Urological Surgeon

Book online
|

Mr Daniel Wilby BM MRCS FRCS (Urol)

Consultant Urological Surgeon

BM MRCS FRCS (Urol)

Mr Daniel Wilby

Consultant Urological Surgeon BM MRCS FRCS (Urol)

Book online
|
BM MRCS FRCS (Urol)

Areas of expertise

  • Bladder cancer
  • Kidney cancer
  • Prostate cancer diagnostics
  • Benign prostatic enlargement
  • Urinary infection

Address

  • London Endometriosis & Advanced Pelvic Surgery

    16 Devonshire Street, London, W1G 7AF

About Mr Daniel Wilby

GMC number: 6051466

Year qualified: 2002

Place of primary qualification: University of Southampton

Areas of expertise

  • Benign prostate hyperplasia
  • Benign prostatic enlargement
  • Bladder cancer
  • Bladder instillation
  • Bladder neck incision
  • Bladder surgery
  • Blood in urine (haematuria)
  • Circumcision
  • Cystoscopy
  • Frenuloplasty (penis)
  • Hydrocelectomy
  • Kidney cancer
  • Kidney cysts
  • Laparoscopic surgery
  • Management of endometriosis affecting the urinary system
  • Orchidectomy
  • Overactive bladder
  • Partial cystectomy
  • Pelvic surgery
  • Prostate biopsy
  • Prostate cancer diagnostics
  • Prostatectomy (TURP)
  • PSA testing
  • Reconstructive surgery
  • Renal cancer
  • Retroperitoneal procedures
  • Robotic cystectomy
  • Robotic nephrectomy
  • Robotic reconstructive surgery
  • Robotic surgery
  • Testicular lumps & swellings
  • Transrectal ultrasound (TRUS)
  • Transurethral resection of a bladder tumour (TURBT)
  • Ureteroscopy
  • Uretric reimplantation
  • Urinary infection
  • Urological cancers
  • Varicocele
  • Vasectomy (male sterilization)

Professional memberships

Royal College of Surgeons of England
European Association of Urology
British Association of Urological Surgeons
General Medical Council

Articles by Mr Daniel Wilby

Role and rationale of gene therapy and other novel therapies in the management of NMIBC

Bladder cancer: new TUR techniques

Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II)

Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic

Trans-obturator tape

Robotic total pelvic exenteration for rectal cancer